NDC 70518-3047-1 - Cefazolin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3047
- Requested NDC
- 70518-3047-1
- Package NDCs from labels
- 70518-3047-1, 70518-3047-0
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2025-07-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cefazolin for Injection, USP | REMEDYREPACK INC. | 2025-07-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3047 | CEFAZOLIN INJECTION, POWDER, FOR SOLUTION [REMEDYREPACK INC.] | 6 | Legacy NDC | 20250418_ec3063e4-b639-4606-9f2e-daa2bb28567e.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefazolin | CEFAZOLIN | Hikma Pharmaceuticals USA Inc. | 26de1ce9-06a9-486f-b27d-2ac635f018d1 | 2026-05-14 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | Civica, Inc. | 9ea55207-6d86-401e-b9b9-73c9534a233f | 2026-05-14 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | Hikma Pharmaceuticals USA Inc. | 1dc9de56-e259-4546-a1db-23119a8a088e | 2026-05-14 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | WG Critical Care, LLC | 4f3a9248-a354-4c77-bf5b-9eed38f00219 | 2026-02-27 | Warnings, Adverse reactions | 1665060 2630753 P380M0454Z |
| Cefazolin | CEFAZOLIN | Hospira, Inc | 62441488-fc97-4535-a249-4485fb075022 | 2026-01-21 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | WG Critical Care, LLC | 00dd6da7-50a8-44c9-b2dc-7948973df392 | 2026-01-07 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | Civica, Inc. | c24e604f-16ca-4945-8e9d-277cc67a8c68 | 2025-11-20 | Warnings, Adverse reactions | P380M0454Z |
| Cefazolin | CEFAZOLIN | Civica, Inc. | 1367568c-7d27-479f-a4c5-58e99942f686 | 2025-11-01 | Warnings, Adverse reactions | 1665060 P380M0454Z |
| CEFAZOLIN | CEFAZOLIN | Henry Schein, Inc. | 197d5702-2c20-480e-8246-4d0d21f871be | 2025-10-27 | Warnings | 1665050 P380M0454Z |
| CEFAZOLIN | CEFAZOLIN | Henry Schein Inc. | 922fb1a1-ad4c-4a12-8d5d-00fe13af18e8 | 2025-10-27 | Warnings, Adverse reactions | P380M0454Z |
| CEFAZOLIN | CEFAZOLIN | Henry Schein, Inc. | 5a8c4bb2-a75e-4d7d-91fb-9a95f04fc94b | 2025-10-27 | Warnings, Adverse reactions | ANDA203661 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | ProPharma Distribution | 3d5cc73c-8a41-b285-e063-6294a90a609f | 2025-08-27 | Warnings, Adverse reactions | ANDA203661 1665050 P380M0454Z |
| 3bccd311-4608-23a2-e063-6294a90a8c40 | ec3063e4-b639-4606-9f2e-daa2bb28567e | 2025-08-07 | Warnings, Adverse reactions | ec3063e4-b639-4606-9f2e-daa2bb28567e | ||
| Cefazolin | CEFAZOLIN | Hikma Pharmaceuticals USA Inc. | 570d2583-9ce7-4941-bf7c-6ebc783c0f2b | 2025-07-25 | Warnings, Adverse reactions | P380M0454Z |
| Cefazolin | CEFAZOLIN | Apotex Corp. | 0422fe47-c372-494f-bac2-612f550b44a4 | 2025-07-15 | Warnings, Adverse reactions | ANDA203661 60505-6142 1665060 2630753 1665050 10b501ca-c77f-4b3f-85df-ddf2715bfcd0 0422fe47-c372-494f-bac2-612f550b44a4 P380M0454Z |
| Cefazolin | CEFAZOLIN | WG Critical Care, LLC | f17160d4-fc42-4f9c-abb8-d04f01ae6dd1 | 2025-04-07 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| Cefazolin Sodium | CEFAZOLIN SODIUM | B. Braun Medical Inc. | 17f8f038-c204-4dab-80d7-6f7ac41ddbec | 2025-03-10 | Warnings, Adverse reactions | 1665060 2630753 1665050 P380M0454Z |
| Cefazolin | CEFAZOLIN | Sandoz Inc | 18e7366a-1b3e-4010-8f4a-dd559d4f2146 | 2025-02-05 | Warnings, Adverse reactions | 1665050 P380M0454Z |
| CEFAZOLIN | CEFAZOLIN SODIUM | Samson Medical Technologies, L.L.C. | cf13db9c-d8a1-489f-9aa0-fc70839d4bbc | 2025-01-08 | Warnings, Adverse reactions | P380M0454Z |
| Cefazolin | CEFAZOLIN | Hikma Pharmaceuticals USA Inc. | 6c7761d3-c154-4802-9876-627cd42913f0 | 2024-12-31 | Warnings, Adverse reactions | 1665060 2630753 P380M0454Z |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.